Vero Biotech

Develops tankless inhaled nitric oxide delivery systems for hospitals.

vero-biotech.comMedical Devices, Biotechnology223 employeesUS
PrivateFounded 2006Debt Financing (2024)Medical device manufacturingInhaled nitric oxide therapyRespiratory delivery systemsClinical training servicesCardiopulmonary medical technology
Showing 13 matching jobs
Title
Quality Assurance Associate
Full Time · 2+ YOE
Atlanta, Georgia, United States · Onsite
Supplier Quality Manager
Full Time · 5+ YOE
Atlanta, Georgia, United States · Onsite
Senior Tax and Compliance Analyst
Full Time, Contract · 3+ YOE
Atlanta, Georgia, United States · Onsite
Financial Specialist
Full Time · 4+ YOE
Sandy Springs, Georgia, United States · Onsite
Procurement Manager
Full Time
Atlanta, Georgia, United States · Hybrid
Manufacturing Technician -Dayshift 6:00am - 4:30pm
Full Time · 3+ YOE
Atlanta, Georgia, United States · Onsite
Project Manager
Full Time · 2+ YOE
Atlanta, Georgia, United States · Onsite
Senior Systems Engineer
Full Time · 7+ YOE
Atlanta, Georgia, United States · Onsite
Systems Test & Verification Engineer
Full Time · 3+ YOE
Atlanta, Georgia, United States · Onsite
Senior Program Manager, R & D New Product Development
Full Time · 5+ YOE
Sandy Springs, Georgia, United States · Onsite
Senior Infrastructure Systems and Cyber Security Engineer
Full Time · 5+ YOE
Atlanta, Georgia, United States · Onsite
Manufacturing Technician Nights
Full Time
Atlanta, Georgia, United States · Onsite
Senior Accountant
Full Time · 2+ YOE
Atlanta, Georgia, United States · Onsite

About Vero Biotech

Activities
Medical device manufacturingInhaled nitric oxide therapyRespiratory delivery systemsClinical training servicesCardiopulmonary medical technology
HeadquartersUS
Industries
Medical DevicesBiotechnology
NameVero Biotech
Employees223
TypePrivate
TaglineDevelops tankless inhaled nitric oxide delivery systems for hospitals.
Founded2,006
Websitevero-biotech.com
Latest Funding RoundDebt Financing
Latest Funding Year2,024
Latest Funding Amount65,000,000
Latest Investors
Horizon Technology Finance